Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
401.00    -5.20 (-1.28%)
Bid:
400.60
Ask:
401.20
Spread: 0.60 (0.15%)
Market Cap: £604.36m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Scheduled Trading Update

22 Jan 2019 07:00

RNS Number : 6874N
Close Brothers Group PLC
22 January 2019
 

 

Scheduled Trading Update

Close Brothers Group plc ("the group" or "Close Brothers") today issues its scheduled pre-close trading update ahead of its 2019 half year end. Close Brothers will be releasing its half year results for the six months ending 31 January 2019 on 12 March 2019.

All statements in this release relate to continuing operations1 over the five months to 31 December 2018 unless otherwise indicated.

Group and divisional performance

The group has achieved a solid performance overall, notwithstanding the difficult trading conditions for our market facing businesses.

The Banking division has continued to perform well and in line with expectations, as we focus on maintaining our disciplined approach to lending and investing to maximise the long-term potential of our businesses.

The loan book grew 3.1% in the period to £7.5 billion (1 August 2018: £7.2 billion2), driven by good new business volumes across the Commercial businesses and in Premium Finance.

Impairment charges remained low, with strong credit performance across all businesses. The net interest margin has remained broadly stable since the last financial year, reflecting our continued pricing discipline.

Winterflood has continued to deliver solid profitability, but volumes and trading income have been significantly lower than the prior year reflecting difficult and volatile equity market conditions, particularly in December.

Asset Management has continued to achieve good net inflows, although these were more than offset by negative market movements, resulting in a 3% decline in managed assets to £10.0 billion at 31 December 2018 (31 July 2018: £10.4 billion) and a decrease in total client assets to £11.7 billion (31 July 2018: £12.2 billion).

Outlook

Overall, we expect a solid outcome for the first half, and remain well positioned for the remainder of the financial year.

 

1 Results from continuing operations exclude the unsecured retail point of sale finance business, which was classified as a discontinued operation in the group's 2018 financial statements.

2 The opening net loan book of £7,239 million reflects the adoption of IFRS 9 at 1 August 2018. For further details see the group's IFRS 9 transition document published on 7 November 2018.

 

 

Enquiries

 

Sophie Gillingham

Close Brothers Group plc

020 7655 3844

Matt Bullivant

Close Brothers Group plc

020 7655 3698

Declan Simpson

Close Brothers Group plc

020 7655 3632

Andy Donald

Maitland

020 7379 5151

 

About Close Brothers

Close Brothers is a leading UK merchant banking group providing lending, deposit taking, wealth management services and securities trading. We employ around 3,300 people, principally in the UK. Close Brothers Group plc is listed on the London Stock Exchange and is a member of the FTSE 250.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTCKDDPABKDNDB
Date   Source Headline
28th Dec 20239:29 amRNSPost-Stabilisation Notice - Close Brothers AT1
27th Dec 20235:30 pmRNSTransaction in Own Shares
22nd Dec 202312:00 pmRNSDirector/PDMR Shareholding
21st Dec 20233:00 pmRNSDirector/PDMR Shareholding
15th Dec 20235:00 pmRNSDirector/PDMR Shareholding
11th Dec 20235:30 pmRNSTransaction in Own Shares
6th Dec 20235:00 pmRNSDirector/PDMR Shareholding
4th Dec 20234:30 pmRNSTransaction in Own Shares
30th Nov 20231:00 pmRNSTotal Voting Rights
29th Nov 20234:30 pmRNSAdditional Tier 1 Securities
28th Nov 20234:45 pmRNSDirector/PDMR Shareholding
27th Nov 20236:00 pmRNSPublication of Offering Circular
22nd Nov 20239:02 amRNSPre Stabilisation Notice - Close Brothers AT1
21st Nov 20235:00 pmRNSHolding(s) in Company
17th Nov 202312:00 pmRNSHolding(s) in Company
16th Nov 20233:00 pmRNSResult of AGM
16th Nov 20237:00 amRNSTrading Statement
13th Nov 20231:00 pmRNSTransaction in Own Shares
8th Nov 20232:00 pmRNSDirector/PDMR Shareholding
6th Nov 20233:30 pmRNSTransaction in Own Shares
3rd Nov 20233:30 pmRNSHolding(s) in Company
31st Oct 20234:00 pmRNSTotal Voting Rights
30th Oct 20231:00 pmRNSTransaction in Own Shares
24th Oct 20231:00 pmRNSHolding(s) in Company
17th Oct 20235:00 pmRNSNotice of Quarterly Trading Update
16th Oct 20235:30 pmRNSTransaction in Own Shares
12th Oct 20235:15 pmRNSNotice of AGM
10th Oct 20232:00 pmRNSTransaction in Own Shares
9th Oct 20236:30 pmRNSDirector/PDMR Shareholding
6th Oct 20232:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20235:30 pmRNSHolding(s) in Company
29th Sep 202311:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSFinal Results
20th Sep 20237:00 amRNSAcquisition
12th Sep 20235:30 pmRNSTransaction in Own Shares
7th Sep 20234:30 pmRNSDirector/PDMR Shareholding
31st Aug 20233:00 pmRNSTotal Voting Rights
29th Aug 20235:00 pmRNSTransaction in Own Shares
14th Aug 20234:00 pmRNSTransaction in Own Shares
9th Aug 20234:00 pmRNSDirector/PDMR Shareholding
7th Aug 20235:30 pmRNSTransaction in Own Shares
4th Aug 20231:00 pmRNSHolding(s) in Company
31st Jul 20235:05 pmRNSTotal Voting Rights
31st Jul 20235:00 pmRNSTransaction in Own Shares
24th Jul 202312:00 pmRNSTransaction in Own Shares
21st Jul 20237:00 amRNSScheduled Trading Update
17th Jul 20236:00 pmRNSTransaction in Own Shares
10th Jul 20234:30 pmRNSTransaction in Own Shares
10th Jul 20234:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.